Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience.

Diagnostic cytopathology - 1 Jul 2015

Son Choonhee, Kang Eun-Ju, Roh Mee Sook

Abstract excerpt

BACKGROUND: Lung cancer therapy is personalized based on the histological subtype and molecular status. Totally, 70% of lung cancer patients present in advanced stages and are diagnosed on small biopsy or cytology specimens, hence an accurate but tissue-sparing approach is necessary. This study aimed to demonstrate efficient utilization of cell block (CB) on transthoracic needle aspiration (TTNA) for lung cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biopsy, Fine-Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Peptide Nucleic Acids

Share to Real-Time Polymerase Chain Reaction

Source

Identifiers

PMID: 25427228
DOI: 10.1002/dc.23237

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience.PMID 25427228Read ↗

Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.Semantic proximity Read ↗

Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.Semantic proximity Read ↗

Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.Semantic proximity Read ↗

Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.Semantic proximity Read ↗

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.Semantic proximity Read ↗

Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.Semantic proximity Read ↗

The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation.Semantic proximity Read ↗

EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.Semantic proximity Read ↗

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.Semantic proximity Read ↗

A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung CancerSemantic proximity Read ↗

Lung cancer cytology and small biopsy specimens: diagnosis, predictive biomarker testing, acquisition, triage, and management.Semantic proximity Read ↗

Cell pellet from fixative medium of transbronchial lung biopsy sample improves lung cancer ancillary test.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.